Morphologic Evidence of Apoptosis in Childhood Acute Myeloblastic Leukemia Treated with High-Dose Methylprednisolone

References

• Kerr J. F. R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Wyllie A.H. Apoptosis: cell death in tissue regulation. J. Pathol 1987; 153: 313–316
   PubMed Web of Science ®Google Scholar
• Baxter G.D., Collins R.J., Harmon B.V., Kumar S., Prentice R.L., Smith P.J., Lavin M.F. Cell death by apoptosis in acute leukemia. J. Pathol. 1989; 158: 123–129
   PubMed Web of Science ®Google Scholar
• Matsubara K., Kubota M., Adachi S., Kuwakado K., Hirota H., Wakazona Y., Akiyama Y., Mikawa H. Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo. Eur. J. Haematol. 1994; 52: 47–52
   PubMed Web of Science ®Google Scholar
• Lotem J., Cragoe E.J., Jr., Sachs L. Rescue from programmed cell death in leukemic and normal myeloid cells. Blood 1991; 78: 953–960
   PubMed Web of Science ®Google Scholar
• Sachs L., Lotem J. Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 1993; 82: 15–21
   PubMed Web of Science ®Google Scholar
• Carson D.A., Ribeiro J.M. Apoptosis and disease. Lancet 1993; 341: 1251–1254
   PubMed Web of Science ®Google Scholar
• Bird C.C., Robertson A. M. G., Read J., Currie A.R. Cytolethal effects of glucocorticoids in human lymphoblastoid cell lines. J. Pathol. 1977; 123: 145–156
   PubMed Web of Science ®Google Scholar
• Robertson A. M. G., Bird C.C., Waddell A.W., Currie A.R. Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells. J. Pathol. 1978; 126: 181–187
   PubMed Web of Science ®Google Scholar
• Blewitt R.W., Abbott A.C., Bird C.C. Mode of cell death induced in human lymphoid cells by high and low doses of glucocorticoid. Br. J. Cancer. 1983; 47: 477–486
   PubMed Web of Science ®Google Scholar
• Martin S.J., Bradley J.G., Cotter T.G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990; 79: 448–453
   PubMed Web of Science ®Google Scholar
• Anzai N., Kawabata H., Hirama T., Masutani H., Ohmari M., Yoshida Y., Okuma M. Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation. Leukemia 1994; 8: 446–453
   PubMed Web of Science ®Google Scholar
• Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 1989; 83: 865–875
   PubMed Web of Science ®Google Scholar
• Hicsönmez G., Özsoylu S., Gürgey A., Zamani V.P., Irken G. High dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia. Eur. J. Haematol. 1989; 48: 498–500
   Google Scholar
• Hicsönmez G., Tuncer A.M., Güler E., Tan E., Tekelioglu M. The potential role of high-dose methylprednisolone on the maturation of leukemic cells in children with acute promyelo-cytic leukemia (APL). Exp. Hematol. 1993; 21: 599–601
   PubMed Web of Science ®Google Scholar
• Hicsönmez G., Özsoylu S., Tuncer A.M., Ertürk G., Özbek N., Karadeniz N. Direct morphological evidence of high dose methylprednisolone induced maturation in children with acute nonlymphoblastic leukemia. Exp. Hematol. 1991; 19: 232–233
   PubMed Web of Science ®Google Scholar
• Hicsönmez G., Tuncer A.M., Jetin M., Gümrük F., Kara A., Yalcin S. Morphologic evidence of in vivo differentiation in acute myeloblastic leukemia. Acta. Haematol. 1994; 90: 214–215
   Web of Science ®Google Scholar
• Lotem J., Sachs L. Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int. J. Cancer. 1975; 15: 731–740
   PubMed Web of Science ®Google Scholar
• Krystosek A., Sachs L. Steroid hormone receptors and the differentiation of myeloid leukemic cells. J. Cell Physiol. 1977; 92: 345–352
   PubMed Web of Science ®Google Scholar
• Honma Y., Kasukabe T., Hozumi M. Relationship between leukomogeneity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells. J. Natl. Cancer. Inst. 1978; 61: 837–841
   PubMed Web of Science ®Google Scholar
• Hill J.M., Marshall G.J., Falco D.J. Massive pred-nisone and prednisolone therapy in leukemia and lymphomas in the adult. J. Am. Geriatr. Soc. 1956; 4: 627–641
   PubMed Web of Science ®Google Scholar
• Ranney H., Gelhorn A. The effect of massive prednisolone therapy on acute leukemia and malignant lymphoma. Am. J. Med. 1957; 22: 405–413
   PubMed Web of Science ®Google Scholar
• Granville N.B., Rubio F., Unugur A., Schulman E., Dameshek W. Treatment of acute leukemia in adults with massive doses of prednisone and prednisolone. N. Eng. J. Med. 1958; 259: 207–213
   PubMed Web of Science ®Google Scholar
• Schuler D., Szende B., Borsi J.D., Marton T., Bocsi J., Magyarossy E., Koos R., Csoka M. Apoptosis a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia. Pediatr. Hematol/Oncol. 1994; 11: 641–649
   PubMed Web of Science ®Google Scholar
• Hicsönmez G., Karadeniz N., Zamani V.P., Tuncer A.M., Gümrttk F., Ertürk G., Gürgey A., Özsoylu S. High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone. Eur. J. Haematol. 1992; 48: 215–220
   PubMed Web of Science ®Google Scholar
• Kasukabe T., Honma Y., Hozumi M., Suda T., Nishii Y. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. Cancer. Res. 1987; 47: 567–572
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell. Growth. and Differ. 1994; 5: 321–327
   PubMedGoogle Scholar
• Kasukabe T., Okabe-Kado J., Hozumi M., Honma Y. Inhibition by interleukin 4 of leukemia inhibitory factor-, Interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes. Cancer Res. 1994; 54: 592–597
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Selective regulation by hydrocorti-sone of induction of in vivo differentiation of myeloid leukemic cells with granulocyte macrophage colony stimulating factor, interleukin 6 and interleukin 1 α. Leukemia 1992; 6: 426–431
   PubMed Web of Science ®Google Scholar
• Williams G.T., Smith C.A., Spooncer E., Dexter T.M., Taylor D.R. Haemopoietic colony stimulating factors promote cell survival by supressing apoptosis. Nature 1990; 343: 76–79
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992; 80: 1750–1757
   PubMed Web of Science ®Google Scholar